3rd Annual UCLA State-of-the-Art in Neuro-Oncology is organized by UCLA Health System and will be held on Feb 10, 2018 at Ronald Reagan UCLA Medical Center, Los Angeles, California, United States of America.
The target audience for this medical event is neurosurgeons, medical oncologists, radiation oncologists, neurologists, allied health professionals, and neurosurgery, neurology and oncology residents and fellows. This CME Conference has been approved for a maximum of 6.75 AMA PRA Category 1 Credits.
Course Description :
The Brain Tumor Center at the David Geffen School of Medicine at UCLA presents its third annual comprehensive update on emergent diagnostic and treatment modalities for the management of brain and spine tumors. This course will focus on the diagnosis and multi- disciplinary management of patients with primary and metastatic brain and spine tumors, and will feature faculty experts from neurosurgery, neuro-oncology, radiation oncology, medical oncology, pain management, neuroradiology, and neuropathology. The program will provide sessions on the latest advances in diagnosis and treatment of brain and spine tumors, including a review of the current state-of-the-art management of these tumors.
Each tumor-specific didactic session will then be followed by case-based presentations demonstrating the multidisciplinary approach of a brain tumor board to personalize care for patients with brain and spine tumors. In addition, we will explore new and emerging techniques for cranial metastases including novel-imaging, MR-guided laser ablation, neo-adjuvant radiation, and emerging chemotherapeutic strategies for metastatic brain tumors. Finally, we will explore the multimodal management of spinal metastasis including novel radiation approaches, surgery, and pain management. This format is intended to encourage and ensure audience participation.
Course Objectives :
At the conclusion of this course, participants should be better able to:
• Recommend the most recent diagnostic, surgical, and pathological advances in the evaluation of patients with brain and spine tumors
• Understand standard and emerging treatments for patients with primary and metastatic brain and spine tumors and the molecular basis of these treatments
• Manage symptoms and complications in patients with brain tumors
• Describe multimodal management of spinal metastases including surgery, radiation, and pain management
additional details will be posted as soon as they are available.